Pharmacology of fluorinated pyrimidines : EniluracilBAKER, Sharyn D.Investigational new drugs. 2000, Vol 18, Num 4, pp 373-381, issn 0167-6997Article

Clinical pharmacokinetics of docetaxel : Recent developmentsBAKER, Sharyn D; SPARREBOOM, Alex; VERWEIJ, Jaap et al.Clinical pharmacokinetics. 2006, Vol 45, Num 3, pp 235-252, issn 0312-5963, 18 p.Article

Castration-Dependent Pharmacokinetics of Docetaxel in Patients With Prostate CancerFRANKE, Ryan M; CARDUCCI, Michael A; RUDEK, Michelle A et al.Journal of clinical oncology. 2010, Vol 28, Num 30, pp 4562-4567, issn 0732-183X, 6 p.Article

A rapid and sensitive method for determination of dimethyl benzoylphenyl urea in human plasma by using LC/MS/MSMING ZHAO; ZABELINA, Yelena; RUDEK, Michelle A et al.Journal of pharmaceutical and biomedical analysis. 2003, Vol 33, Num 4, pp 725-733, issn 0731-7085, 9 p.Article

Population Pharmacokinetic-Pharmacodynamic Model of the Vascular-Disrupting Agent 5,6 -Dimethylxanthenone-4-Acetic Acid in Cancer PatientsJING LI; JAMESON, Michael B; BAGULEY, Bruce C et al.Clinical cancer research. 2008, Vol 14, Num 7, pp 2102-2110, issn 1078-0432, 9 p.Article

Validation and implementation of a liquid chromatography/tandem mass spectrometry assay to quantitate ABT-751, ABT-751 glucuronide, and ABT-751 sulfate in human plasma for clinical pharmacology studiesRUDEK, Michelle A; MING ZHAO; PING HE et al.Journal of pharmaceutical and biomedical analysis. 2006, Vol 42, Num 2, pp 253-260, issn 0731-7085, 8 p.Article

A liquid chromatography/tandem mass spectrometry assay to quantitate MS-275 in human plasmaMING ZHAO; RUDEK, Michelle A; MNASAKANYAN, Aleksandr et al.Journal of pharmaceutical and biomedical analysis. 2007, Vol 43, Num 2, pp 784-787, issn 0731-7085, 4 p.Article

Clinical pharmacokinetics of unbound docetaxel: Role of polysorbate 80 and serum proteinsLOOS, Walter J; BAKER, Sharyn D; VERWEIJ, Jaap et al.Clinical pharmacology and therapeutics. 2003, Vol 74, Num 4, pp 364-371, issn 0009-9236, 8 p.Article

Quantification of sunitinib in human plasma by high-performance liquid chromatography-tandem mass spectrometryMINKIN, Patton; MING ZHAO; ZHAOYUAN CHEN et al.Journal of chromatography. B. 2008, Vol 874, Num 1-2, pp 84-88, issn 1570-0232, 5 p.Article

Specific method for determination of OSI-774 and its metabolite OSI-420 in human plasma by using liquid chromatography-tandem mass spectrometryMING ZHAO; PING HE; RUDEK, Michelle A et al.Journal of chromatography. B. 2003, Vol 793, Num 2, pp 413-420, issn 1570-0232, 8 p.Article

Determination of the docetaxel vehicle, polysorbate 80, in patient samples by liquid chromatography-tandem mass spectrometrySPARREBOOM, Alex; MING ZHAO; BRAHMER, Julie R et al.Journal of chromatography. B, Biomedical sciences and applications. 2002, Vol 773, Num 2, pp 183-190, issn 1387-2273Article

Differential metabolism of gefitinib and erlotinib by human cytochrome P450 enzymesJING LI; MING ZHAO; PING HE et al.Clinical cancer research. 2007, Vol 13, Num 12, pp 3731-3737, issn 1078-0432, 7 p.Article

Phase II, Randomized, Placebo-Controlled Trial of Neoadjuvant Celecoxib in Men With Clinically Localized Prostate Cancer: Evaluation of Drug-Specific BiomarkersANTONARAKIS, Emmanuel S; HEATH, Elisabeth I; BAKER, Sharyn D et al.Journal of clinical oncology. 2009, Vol 27, Num 30, pp 4986-4993, issn 0732-183X, 8 p.Article

Phase I study of continuous weekly dosing of dimethylamino benzoylphenylurea (BPU) in patients with solid tumoursMESSERSMITH, Wells A; RUDEK, Michelle A; BAKER, Sharyn D et al.European journal of cancer (1990). 2007, Vol 43, Num 1, pp 78-86, issn 0959-8049, 9 p.Article

Ductal access for prevention and therapy of mammary tumorsMURATA, Satoshi; KOMINSKY, Scott L; REILLY, R. Todd et al.Cancer research (Baltimore). 2006, Vol 66, Num 2, pp 638-645, issn 0008-5472, 8 p.Article

Pharmacogenetics of ABCG2 and adverse reactions to gefitinibCUSATIS, George; GREGORC, Vanesa; BAKER, Sharyn D et al.Journal of the National Cancer Institute. 2006, Vol 98, Num 23, pp 1739-1742, issn 0027-8874, 4 p.Article

Relationship of systemic exposure to unbound docetaxel and neutropeniaBAKER, Sharyn D; JING LI; TEN TIJE, Albert J et al.Clinical pharmacology and therapeutics. 2005, Vol 77, Num 1, pp 43-53, issn 0009-9236, 11 p.Article

Prospective evaluation of the pharmacokinetics and toxicity profile of docetaxel in the elderlyTEN TIJE, Albert J; VERWEIJ, Jaap; CARDUCCI, Michael A et al.Journal of clinical oncology. 2005, Vol 23, Num 6, pp 1070-1077, issn 0732-183X, 8 p.Conference Paper

Phase II Study of troxacitabine, a novel dioxolane nucleoside analog, in patients with refractory leukemiaGILES, Francis J; GARCIA-MANERO, Guillermo; KANTARJIAN, Hagop M et al.Journal of clinical oncology. 2002, Vol 20, Num 3, pp 656-664, issn 0732-183XArticle

Contribution of Abcc4-Mediated Gastric Transport to the Absorption and Efficacy of DasatinibFURMANSKI, Brian D; SHUIYING HU; FUJITA, Ken-Ichi et al.Clinical cancer research (Print). 2013, Vol 19, Num 16, pp 4359-4370, issn 1078-0432, 12 p.Article

Docetaxel metabolism is not altered by imatinib: findings from an early phase study in metastatic breast cancerCONNOLLY, Roisin M; RUDEK, Michelle A; DAVIDSON, Nancy E et al.Breast cancer research and treatment. 2011, Vol 127, Num 1, pp 153-162, issn 0167-6806, 10 p.Article

Activated pregnenolone X-receptor is a target for ketoconazole and its analogsHONGWEI WANG; HAIYAN HUANG; HAO LI et al.Clinical cancer research. 2007, Vol 13, Num 8, pp 2488-2495, issn 1078-0432, 8 p.Article

Evaluation of alternate size descriptors for dose calculation of anticancer drugs in the obeseSPARREBOOM, Alex; WOLFF, Antonio C; MATHIJSSEN, Ron H. J et al.Journal of clinical oncology. 2007, Vol 25, Num 30, pp 4707-4713, issn 0732-183X, 7 p.Article

Phase I and pharmacokinetic study of pemetrexed administered every 3 weeks to advanced cancer patients with normal and impaired renal functionMITA, Alain C; SWEENEY, Christopher J; MOLPUS, Kathleen et al.Journal of clinical oncology. 2006, Vol 24, Num 4, pp 552-562, issn 0732-183X, 11 p.Article

Effect of common CYP3A4 and CYP3A5 variants on the pharmacokinetics of the cytochrome P450 3A phenotyping probe midazolam in cancer patientsLEPPER, Erin R; BAKER, Sharyn D; INGERSOLL, Roxann G et al.Clinical cancer research. 2005, Vol 11, Num 20, pp 7398-7404, issn 1078-0432, 7 p.Article